The effects of insulin given prior to release of cross-clamp on coronary sinus lactate levels in coronary artery surgery;Koroner arter cerrahisinde kros-klemp alinmadan önce yapilan insülinin koroner sinüs laktat seviyeleri üzerine etkileri

Anadolu Kardiyoloji Dergisi

Volumn 6, Issue 3, 2006, Pages 248-252

  Savaşkan, Dilek ^c   Yurtseven, Nurgül ^c,d   Tuygun, Abdullah Kemal ^a   Aksoy, Pelin ^b   Canik, Sevim ^c  

^a Kalp Damar Cerrahisi Klinikleri   (Turkey)

^b Anadolu Saglik Merkezi Hospital   (Turkey)

^c DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d NONE   (Turkey)

Author keywords

Coronary artery bypass surgery; Glucose; Insulin

Indexed keywords

CREATINE KINASE MB; GLUCOSE; INSULIN; LACTIC ACID; SODIUM CHLORIDE;

AORTA BALLOON; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY REPERFUSION; CORONARY SINUS; CORONARY SINUS BLOOD FLOW; CREATINE KINASE BLOOD LEVEL; DEFIBRILLATION; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; INOTROPISM; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LENGTH OF STAY; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SINGLE DRUG DOSE;

ADULT; AGED; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; LACTIC ACID; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TURKEY;

EID: 33748712653     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mauney MC, Kron IL. The physiologic basis of warm cardioplegia. Ann Thorac Surg 1995; 60: 819-23.
2. Nicolini F, Beghi C, Muscari C, Agostinelli A, Maria Budillon A, Spaggiari I, et al. Myocardial protection in adult cardiac surgery: current options and future challenges. Eur J Cardiothorac Surg 2003; 24: 986-93.
3. Rumelin A, Nietgen G, Pirlich M, Thum P, Schafers HJ, von zur Muhlen A, et al. Postoperative pattern of various hormonal and metabolic variables. A pilot study in patients without complications following cardiac surgery. Curr Med Res Opin 1999; 15: 339-48.
4. Girard C, Quentin P, Bouvier H, Blanc P, Bastien O, Lehott JJ, et al. Glucose and insulin supply before cardiopulmonary bypass in cardiac surgery. Ann Tholrac Surg 1992; 54: 259-63.
5. Haider W, Benzer H, Schütz W, Wolner E. Improvement of cardiac preservation by preoperative high insulin supply. J Thorac Cardiovasc Surg 1984; 88: 294-300.
6. Careaga G, Salazar D, Tellez S, Sanchez O, Borrayo G, Arguero R. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients. Arch Med Res 2001; 32: 296-9.
7. Russell RR 3rd, Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol 1991; 261: 1756-62.
8. Rao V, Merante F, Weisel RD, Shirai T, Ikonomidis JS, Cohen G, et al,. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. J Thorac Cardiovasc Surg 1998; 116: 485-94.
9. Quinones-Galvan A, Ferrannini E. Metabolic effects of glucose-insulin infusions: myocardium and whole body. Curr Opin Clin Nutr Metab Care 2001; 4:157-63.
10. Szabo Z, Arnqvist H, Hakanson E, Jorfeldt L, Svedjeholm R. Effects, of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes. Clin Sci (Lond) 2001; 101:37-43.
11. Barton RN. Neuroendocrine mobilization of body fuels after injury. Br Med Bull 1985;41:218-25.
12. Svensson S, Svedjeholm R, Ekroth R, Milocco I, Nilsson F, Sabel KG, et al. Trauma metabolism of the heart: Uptakes of substrates and effects of insulin early after cardiac operations. J Thorac Cardiovasc Surg 1990; 99: 1063-73.
13. Reves JG, Buttner E, Karp RB, Oparil S, McDanial HG, Smith LR. Elevated catecholamines during cardiac surgery: consequences of reperfusion of the postarrested heart. Am J Cardiol 1984; 53: 722-8.
14. Lazar HL. The insulin cardioplegia Trial. J Thorac Cardiovasc Surg 2002; 123: 842-4.
15. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, et al. Metabolic modulation of acute myocardial infarction: the ECLA glucose-insulin-potassium pilot trial. Circulation 1998; 98: 2227-34.
16. Lazar HL, Zhang X, Rivers S, Bernard S, Apstein CS. Limiting ischemic damage during urgent revascularization using glucose-insulin-potassium solutions. Ann Thorac Surg 1995; 60: 411-6.
17. Kjellman UW, Bjork K, Dahlin A, Ekroth R, Kirno K, Svensson G, et al. Insulin (GIK) improves myocardial metabolism in patients during blood cardioplegia. Scan Cardiovasc J 2000; 34: 321-30.
18. Kim HJ, Han SW. Therapeutic approach to hyperkalemia. Nephron 2002; 92 Suppl 1:33-40.
19. Greenberg A. Hyperkalemia: treatment options. Semin Nephrol 1998; 18: 46-57,
20. Hewitt RL, Lolley DM, Adrouny GA, Drapanas TH. Protective effect of glicogen and glucose on the anoxic arrested heart. Surgery 1974; 75: 1-10.
21. Rudez I, Sutlic Z, Husedzinovic I, Biocina B, Ivancan V. The importance of glucose-insulin-potassium with cardiopulmonary bypass prior to cardioplegic arrest in open-heart surgery. Lijec Vjesn. 1995; 117 Suppl 2: 105-6.
22. Rao V, Borger M, Weisel RD, Ivanov J, Christakis GT, Cohen G, et al: Insulin cardioplegia for elective coronary bypass surgery. J Thorac Cardiovasc Surg 2000; 119: 1176-84.